pENTR-HLA-B0702-His
(Plasmid
#104849)
-
PurposeHLA-B0702 his tagged
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 104849 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepENTR
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 2580
- Total vector size (bp) 3688
-
Vector typeentry vector for Gateway system
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namemajor histocompatibility complex, class I, B
-
Alt nameHLA-B0702
-
Alt nameB*07:02:01:01
-
SpeciesH. sapiens (human)
-
Entrez GeneHLA-B (a.k.a. AS, B-4901, HLAB)
- Promoter none
-
Tag
/ Fusion Protein
- his (C terminal on insert)
Cloning Information
- Cloning method TOPO Cloning
- 5′ sequencing primer CAG GAA ACA GCT ATG ACC
- 3′ sequencing primer TGT AAA ACG ACG GCC AGT (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pENTR-HLA-B0702-His was a gift from Sébastien Walchli (Addgene plasmid # 104849 ; http://n2t.net/addgene:104849 ; RRID:Addgene_104849) -
For your References section:
Breadth and Dynamics of HLA-A2- and HLA-B7-Restricted CD8(+) T Cell Responses against Nonstructural Viral Proteins in Acute Human Tick-Borne Encephalitis Virus Infection. Lampen MH, Uchtenhagen H, Blom K, Varnaite R, Pakalniene J, Dailidyte L, Walchli S, Lindquist L, Mickiene A, Michaelsson J, Schumacher TN, Ljunggren HG, Sandberg JK, Achour A, Gredmark-Russ S. Immunohorizons. 2018 Jul 2;2(6):172-184. doi: 10.4049/immunohorizons.1800029. 10.4049/immunohorizons.1800029 PubMed 31022685